Prevalence and co-existence of cardiometabolic risk factors and associations with nutrition-related and socioeconomic indicators in a national sample of Gambian women.
Adolescent
Adult
C-Reactive Protein
/ metabolism
Cardiometabolic Risk Factors
Cardiovascular Diseases
/ blood
Child
Child, Preschool
Cross-Sectional Studies
Female
Gambia
/ epidemiology
Glycated Hemoglobin
/ metabolism
Humans
Infant
Infant, Newborn
Middle Aged
Obesity
/ blood
Orosomucoid
/ metabolism
Prediabetic State
/ blood
Prevalence
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
08 06 2021
08 06 2021
Historique:
received:
22
02
2021
accepted:
11
05
2021
entrez:
9
6
2021
pubmed:
10
6
2021
medline:
21
10
2021
Statut:
epublish
Résumé
Cardiovascular diseases (CVD) are on the rise in Sub-Saharan Africa, and a large proportion of the adult population is thought to suffer from at least one cardiometabolic risk factor. This study assessed cardiometabolic risk factors and the contribution of nutrition-related indicators in Gambian women. The prevalence and co-existence of diabetes (elevated glycated hemoglobin (HbA1c ≥ 6.5%) or prediabetes (HbA1c ≥ 5.7% to < 6.5%), hypertension (systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg), obesity (body mass index (BMI) ≥ 30.0) and inflammation (C-reactive protein (CRP) > 3 mg/L or alpha-1-acid glycoprotein (AGP) > 1 g/L) and the contribution of nutrition related and socioeconomic indicators were measured in non-pregnant women 15-49 years of age in the Gambia using data from a nationally representative cross-sectional stratified survey. Nationally, 54.5% (95% CI: 47.4, 61.4) of 1407 women had elevated HbA1c. Of these, 14.9% were diabetic and 85.1% were prediabetic. Moreover, 20.8% (95% CI 17.8, 20.0) of 1685 women had hypertension, 11.1% (95% CI 9.0, 13.7) of 1651 were obese and 17.2% (95% CI 5.1, 19.6) of 1401 had inflammation. At least one of the aforementioned cardiometabolic risk factor was present in 68.3% (95% CI 63.0, 73.1) of women. Obesity increased the risk of hypertension (aRR 1.84; 95% CI 1.40, 2.41), diabetes (aRR 1.91; 95% CI 1.29, 2.84), elevated HbA1c (aRR 1.31; 95% CI 1.14, 1.51) and inflammation (aRR 3.47; 95% CI 2.61, 4.61). Inflammation increased the risk of hypertension (aRR 1.42; 95% CI 1.14, 1.78). Aging increased the risk of hypertension, obesity and inflammation. Further, inadequate sanitation increased the risk for diabetes (aRR 1.65; 95% CI 1.17, 2.34) and iron deficiency increased the risk of elevated HbA1c (aRR 1.21; 95% CI 1.09, 1.33). The high prevalence of cardiometabolic risk factors and their co-existence in Gambian women is concerning. Although controlling obesity seems to be key, multifaceted strategies to tackle the risk factors separately are warranted to reduce the prevalence or minimize the risk of CVD.
Identifiants
pubmed: 34103653
doi: 10.1038/s41598-021-91592-7
pii: 10.1038/s41598-021-91592-7
pmc: PMC8187481
doi:
Substances chimiques
Glycated Hemoglobin A
0
Orosomucoid
0
hemoglobin A1c protein, human
0
C-Reactive Protein
9007-41-4
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
12057Subventions
Organisme : Medical Research Council
ID : MC_U123292701
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00026/3
Pays : United Kingdom
Références
Nature. 2019 Jun;570(7760):189-193
pubmed: 31092927
Rev Epidemiol Sante Publique. 1999 Dec;47(6):593-604
pubmed: 10673593
BMJ. 2016 Nov 23;355:i5953
pubmed: 27881363
Diabet Med. 2004 Mar;21(3):203-7
pubmed: 15008827
FAO Food Nutr Pap. 1994;56:1-57
pubmed: 7925867
Int J Epidemiol. 2018 Jun 1;47(3):860-871
pubmed: 29394353
Stroke. 2015 May;46(5):e121-2
pubmed: 25873596
Lancet Glob Health. 2020 Jan;8(1):e123-e133
pubmed: 31839128
Diabetes Res Clin Pract. 2014 Feb;103(2):197-205
pubmed: 24315460
Diabetologia. 2015 Jul;58(7):1409-21
pubmed: 25994072
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
Eur Heart J. 2008 Dec;29(24):2959-71
pubmed: 18775919
Curr Obes Rep. 2014 Dec;3(4):422-31
pubmed: 26626919
BMC Public Health. 2011 Jul 14;11:564
pubmed: 21756350
Diabetes Care. 2010 Jan;33(1):95-7
pubmed: 19808920
Bull World Health Organ. 2013 Sep 1;91(9):671-682D
pubmed: 24101783
Clin Diabetes Endocrinol. 2019 Feb 14;5:2
pubmed: 30783538
Lancet Diabetes Endocrinol. 2016 Feb;4(2):148-58
pubmed: 26656292
Trop Med Int Health. 1997 Nov;2(11):1039-48
pubmed: 9391506
Nutrients. 2019 Sep 23;11(10):
pubmed: 31547543
Lancet Infect Dis. 2009 Dec;9(12):737-46
pubmed: 19926034
Med Clin North Am. 2011 Mar;95(2):327-39, vii-viii
pubmed: 21281836
Circulation. 2004 Jun 1;109(21 Suppl 1):II2-10
pubmed: 15173056
J Am Coll Cardiol. 2010 Mar 30;55(13):1310-7
pubmed: 20338491
J Am Coll Cardiol. 2012 Feb 14;59(7):635-43
pubmed: 22322078
Diabetes Care. 2010 Jul;33(7):1665-73
pubmed: 20587727
PLoS One. 2019 Apr 5;14(4):e0214934
pubmed: 30951534
Diabetes Care. 2015 Sep;38(9):1758-67
pubmed: 26153272
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Diabetes Care. 2000 Feb;23(2):187-91
pubmed: 10868829
Am J Clin Nutr. 2017 Jul;106(Suppl 1):348S-358S
pubmed: 28615263
Diabetes Metab Res Rev. 2017 Oct;33(7):
pubmed: 28444863
Arch Iran Med. 2015 Oct;18(10):713-9
pubmed: 26443254
Clin Infect Dis. 2005 Aug 1;41(3):281-8
pubmed: 16007521
Eur Heart J. 2018 Oct 7;39(38):3483-3487
pubmed: 30295766
BMJ Open. 2016 Dec 13;6(12):e012255
pubmed: 27965249
Transl Res. 2016 Jan;167(1):257-80
pubmed: 26207884
Gut. 2004 Oct;53(10):1437-44
pubmed: 15361491
J Nutr. 2004 Nov;134(11):3127-32
pubmed: 15514286
Int Health. 2010 Sep;2(3):172-80
pubmed: 24037697
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
J Dev Orig Health Dis. 2017 Jun;8(3):337-348
pubmed: 28264759
Global Health. 2009 Sep 14;5:9
pubmed: 19751503
Lancet Glob Health. 2019 Oct;7(10):e1375-e1387
pubmed: 31537368
Diabetologia. 2007 Mar;50(3):549-54
pubmed: 17187246
Diabetes Care. 2010 Mar;33(3):580-2
pubmed: 20009099
Cardiol Res Pract. 2014;2014:605810
pubmed: 24653858
Mediators Inflamm. 2010;2010:
pubmed: 20706689
Am J Clin Nutr. 2010 Sep;92(3):546-55
pubmed: 20610634
Lancet Glob Health. 2019 Oct;7(10):e1295-e1296
pubmed: 31537347
Int J Physiol Pathophysiol Pharmacol. 2019 Jun 15;11(3):45-63
pubmed: 31333808
Hypertension. 2020 Feb;75(2):477-482
pubmed: 31884854